Maine CDC Information
- Health Topics A-Z
- Conferences & Events
- Data and Reports
- Maine CDC Rules
- Public Health Training
- State Health Improvement Plan
- About Us
District Public Health
- Local Health Officers
- Local Public Health Districts
- Public Health Emergency Preparedness
- Statewide Coordinating Council
Information for Health Care Providers
Maine CDC Health Advisory
January 3, 2022
US CDC: Using Therapeutics to Prevent and Treat COVID-19
The SARS-CoV-2 Omicron variant has quickly become the dominant variant of concern in the United States and is present in all 50 states. The Centers for Disease Control and Prevention (CDC) recommends that eligible individuals receive all vaccines and booster shots as the best preventive measure available against severe disease, hospitalizations, and death due to COVID-19. Therapeutics are also available for preventing and treating COVID-19 in specific at-risk populations. These therapeutics differ in efficacy, route of administration, risk profile, and whether they are authorized by the U.S Food and Drug Administration (FDA) for adults only or adults and certain pediatric populations. Some therapeutics are in short supply, but availability is expected to increase in the coming months. This Health Alert Network (HAN) Health Advisory serves to familiarize healthcare providers with available therapeutics, understand how and when to prescribe and prioritize them, and recognize contraindications.
